{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:44:27Z","timestamp":1783035867760,"version":"3.54.6"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejphar.2023.175997","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T20:28:37Z","timestamp":1691872117000},"page":"175997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis"],"prefix":"10.1016","volume":"956","author":[{"given":"Maroua","family":"Ferhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0384-978X","authenticated-orcid":false,"given":"Irina","family":"Mirkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-7453","authenticated-orcid":false,"given":"Julia","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7318-479X","authenticated-orcid":false,"given":"Gregor","family":"Rossmueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-969X","authenticated-orcid":false,"given":"Alexander","family":"Schinagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolf","family":"Kerschbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Landlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1108","key":"10.1016\/j.ejphar.2023.175997_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/postgradmedj-2017-134934","article-title":"Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis","volume":"94","author":"Bae","year":"2018","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ejphar.2023.175997_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.gene.6363867","article-title":"A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis","volume":"3","author":"Baugh","year":"2002","journal-title":"Gene Immun."},{"key":"10.1016\/j.ejphar.2023.175997_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-017-0622-4","article-title":"Arthritis models: usefulness and interpretation","author":"Bessis","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175997_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","article-title":"Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic Lupus Erythematosus","volume":"23","author":"Bilsborrow","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2023.175997_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2016.1251582","article-title":"MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development","author":"Bloom","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.ejphar.2023.175997_bib6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/eji.1830250508","article-title":"Biphasic effect of interferon-\u03b3 in murine collagen-induced arthritis","volume":"25","author":"Boissier","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175997_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","article-title":"Views on glucocorticoid therapy in rheumatology: the age of convergence","volume":"16","author":"Buttgereit","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2\u20136","key":"10.1016\/j.ejphar.2023.175997_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1615\/CritRevImmunol.v37.i2-6.90","article-title":"Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system","volume":"37","author":"Calandra","year":"2017","journal-title":"Crit. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175997_bib9","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2023.175997_bib10","series-title":"Assay and Method for Determining CDC Eliciting Antibodies","author":"Dengl","year":"2017"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175997_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","article-title":"Emerging functions of IL-33 in homeostasis and immunity","volume":"40","author":"Dwyer","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175997_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1073\/pnas.63.1.78","article-title":"The covalent structure of an entire GammaG immunoglobulin molecule","volume":"63","author":"Edelman","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2023.175997_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02308","article-title":"The impact of invariant NKT cells in sterile inflammation: the possible contribution of the alarmin\/cytokine IL-33","author":"Ferhat","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.175997_bib14","doi-asserted-by":"crossref","unstructured":"Firestein, Gary, and Iain B Mcinnes. n.d. \u201cImmunopathogenesis of Rheumatoid Arthritis.\u201d Accessed January 18, 2023. https:\/\/doi.org\/10.1016\/j.immuni.2017.02.006.","DOI":"10.1016\/j.immuni.2017.02.006"},{"issue":"7","key":"10.1016\/j.ejphar.2023.175997_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.ejphar.2023.175997_bib16","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/art.24126","article-title":"Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses","volume":"58","author":"Fujimoto","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"16","key":"10.1016\/j.ejphar.2023.175997_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164968","article-title":"The novel role of MIF in the secretion of IL-25, IL-31, and IL-33 from PBMC of patients with rheumatoid arthritis","volume":"26","author":"Garc\u00eda-Arellano","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175997_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2018.11.003","article-title":"Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets","author":"G\u00fcnther","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175997_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02619-3","article-title":"Isopsoralen ameliorates rheumatoid arthritis by targeting MIF","volume":"23","author":"Han","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2023.175997_bib20","article-title":"Macrophage migration inhibitory factor A central regulator of wound healing","volume":"167","author":"Hardman","year":"2005","journal-title":"Cell Injury, Repair, Aging and Apoptosis American Journal of Pathology"},{"issue":"6","key":"10.1016\/j.ejphar.2023.175997_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"SMASH recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175997_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/art.1780390513","article-title":"Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1 mice: a comparative study using anti-TNF\u03b1, anti-IL-1\u03b1\/\u03b2, and IL-1Ra","volume":"39","author":"Joosten","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2023.175997_bib23","series-title":"Sequences of Proteins of Immunological Interest","author":"Kabat","year":"1991"},{"key":"10.1016\/j.ejphar.2023.175997_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0162-3109(00)00248-4","article-title":"Modulation of collagen-induced arthritis by IL-4 and dexamethasone: the synergistic effect of IL-4 and dexamethasone on the resolution of CIA","volume":"49","author":"Kang","year":"2000","journal-title":"Immunopharmacology"},{"issue":"19","key":"10.1016\/j.ejphar.2023.175997_bib25","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/bioinformatics\/bts474","article-title":"Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood","volume":"28","author":"Lee","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2023.175997_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","article-title":"MACROPHAGE migration inhibitory factor in rheumatoid arthritis evidence of proinflammatory function and regulation by glucocorticoids","volume":"42","author":"Leech","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2023.175997_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.100956","article-title":"Multi-organ single-cell analysis reveals an on\/off switch system with potential for personalized treatment of immunological diseases","author":"Lilja","year":"2023","journal-title":"Cell Reports Medicine"},{"issue":"10\u201311","key":"10.1016\/j.ejphar.2023.175997_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clinbiochem.2012.03.012","article-title":"Association of MIF in serum and synovial fluid with severity of knee osteoarthritis","volume":"45","author":"Liu","year":"2012","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175997_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1172\/JCI11064","article-title":"Amelioration of collagen-induced arthritis by thrombin inhibition","volume":"107","author":"Marty","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175997_bib30","series-title":"Semiautomated Image Analysis of High Contrast Tissue Areas Using Hue\/Saturation\/Brightness Based Color Filtering","author":"Mezei","year":"2011"},{"key":"10.1016\/j.ejphar.2023.175997_bib31","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.11.5514","article-title":"Macrophage migration inhibitory factor I s involved in the pathogenesis of collagen type 11-induced arthritis in mice","volume":"158","author":"Mikulowska","year":"1997","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.ejphar.2023.175997_bib32","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1074\/jbc.274.25.18100","article-title":"Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action","volume":"274","author":"Mitchell","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175997_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/rheumatology\/41.5.558","article-title":"Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations","volume":"41","author":"Morand","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2023.175997_bib61","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/annrheumdis-2016-210713","article-title":"et alEfficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Nam","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"19","key":"10.1016\/j.ejphar.2023.175997_bib34","first-page":"3210","article-title":"Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem\/progenitor cells","volume":"139","author":"Ohta","year":"2012","journal-title":"Development (Camb.)"},{"key":"10.1016\/j.ejphar.2023.175997_bib35","unstructured":"Onodera, Shin, Hiroshi Tanji, Kouji Suzuki, Kiyoshi Kaneda, Yuka Mizue, Akira Sagawa, and Jun Nishihira. n.d. \u201cHigh Expression Of Macrophage Migration Inhibitory Factor In The Synovial Tissues Of Rheumatoid Joints.\u201d."},{"key":"10.1016\/j.ejphar.2023.175997_bib36","author":"Onodera"},{"issue":"4","key":"10.1016\/j.ejphar.2023.175997_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/ar2021","article-title":"Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis","volume":"8","author":"Pakozdi","year":"2006","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2023.175997_bib38","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1002\/art.21285","article-title":"Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor","volume":"52","author":"Radstake","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"JAN","key":"10.1016\/j.ejphar.2023.175997_bib39","first-page":"25","article-title":"Plasma levels of macrophage migration inhibitory factor and D-dopachrome tautomerase show a highly specific profile in early life","volume":"8","author":"Roger","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2023.175997_bib40","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-22-0676","article-title":"Preclinical evaluation of ON203, A novel bioengineered MAb targeting oxidized macrophage migration inhibitory factor as an anticancer therapeutic","author":"Rossmueller","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"issue":"10","key":"10.1016\/j.ejphar.2023.175997_bib41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2174\/1566524019666190129123240","article-title":"Th1\/Th17 cytokine profile is induced by macrophage migration inhibitory factor in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"18","author":"Garc\u00eda-Arellano","year":"2018","journal-title":"Curr. Mol. Med."},{"issue":"45","key":"10.1016\/j.ejphar.2023.175997_bib42","doi-asserted-by":"crossref","first-page":"73486","DOI":"10.18632\/oncotarget.11970","article-title":"Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer","volume":"7","author":"Schinagl","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ejphar.2023.175997_bib43","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/acs.biochem.7b01156","article-title":"Role of the cysteine 81 residue of macrophage migration inhibitory factor as a molecular redox switch","volume":"57","author":"Schinagl","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2023.175997_bib44","series-title":"Improved Fc Silenced Anti-oxMIF Antibodies with Reduced Aggregation Potential and Reduced Hydrophobicity","author":"Schinagl","year":"2023"},{"issue":"May","key":"10.1016\/j.ejphar.2023.175997_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.redox.2017.11.028","article-title":"Post-translational regulation of macrophage migration inhibitory factor: basis for functional fine-tuning","volume":"15","author":"Schindler","year":"2018","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.ejphar.2023.175997_bib46","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/art.23904","article-title":"Interactions of T Helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells","volume":"58","author":"Schurigt","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175997_bib47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ejphar.2023.175997_bib48","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00296-013-2713-4","article-title":"Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K\/BxN serum-induced model of arthritis","volume":"33","author":"Singh","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ejphar.2023.175997_bib49","series-title":"Macrophage Migration Inhibitory Factor Family Proteins Are Multitasking Cytokines in Tissue Injury.\u201d Cellular And Molecular Life Sciences","author":"Song","year":"2022"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175997_bib50","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175997_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clim.2007.03.004","article-title":"In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models","volume":"123","author":"Stojanovic","year":"2007","journal-title":"Clin. Immunol."},{"issue":"May","key":"10.1016\/j.ejphar.2023.175997_bib52","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175997_bib53","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4049\/jimmunol.1500572","article-title":"Selective targeting of a disease-related conformational isoform of macrophage migration inhibitory factor ameliorates inflammatory conditions","volume":"195","author":"Thiele","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175997_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005475","article-title":"OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases","author":"Thiele","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"8","key":"10.1016\/j.ejphar.2023.175997_bib55","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/ard.2007.086728","article-title":"Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis","volume":"68","author":"Wijbrandts","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175997_bib56","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.humimm.2012.07.043","article-title":"Association of MIF\u2212173G\/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: a meta-analysis","volume":"73","author":"Xie","year":"2012","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175997_bib57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI81937","article-title":"Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus","volume":"126","author":"Yao","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175997_bib58","author":"Yap"},{"issue":"49","key":"10.1016\/j.ejphar.2023.175997_bib59","doi-asserted-by":"crossref","first-page":"E7917","DOI":"10.1073\/pnas.1612717113","article-title":"MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis","volume":"113","author":"Yoo","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2023.175997_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8584930","article-title":"Macrophage migration inhibitory factor as an emerging drug target to regulate antioxidant response element system","author":"Yukitake","year":"2017","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923005095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:19:48Z","timestamp":1728407988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923005095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":61,"alternative-id":["S0014299923005095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175997","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175997"}}